As shown in Fig. 2D, elevated protein expression of MAP2K3 was observed by IHC in normal epithelial (n = 140) when compared to case‐matched carcinoma in situ (CIS) (n = 12) and ESCC tissue(n = 140). This evidence concerns the gene MAP2K3 and in situ carcinoma.